Abstract
3546 Background: This first-in-human study (NCT01577758) assessed the safety and tolerability, dose limiting toxicities (DLTs), maximum tolerated dose (MTD), pharmacokinetics, and preliminary antit...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have